ATE382327T1 - Verwendung von salicyloyl-sphingoidbase zur behandlung oder verhinderung von cellilitis - Google Patents

Verwendung von salicyloyl-sphingoidbase zur behandlung oder verhinderung von cellilitis

Info

Publication number
ATE382327T1
ATE382327T1 AT05014134T AT05014134T ATE382327T1 AT E382327 T1 ATE382327 T1 AT E382327T1 AT 05014134 T AT05014134 T AT 05014134T AT 05014134 T AT05014134 T AT 05014134T AT E382327 T1 ATE382327 T1 AT E382327T1
Authority
AT
Austria
Prior art keywords
salicyloyl
cellilitis
treat
prevent
sphingoid base
Prior art date
Application number
AT05014134T
Other languages
English (en)
Inventor
Mike Dr Farwick
Anthony Rawlings
Original Assignee
Evonik Goldschmidt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Goldschmidt Gmbh filed Critical Evonik Goldschmidt Gmbh
Application granted granted Critical
Publication of ATE382327T1 publication Critical patent/ATE382327T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05014134T 2005-06-30 2005-06-30 Verwendung von salicyloyl-sphingoidbase zur behandlung oder verhinderung von cellilitis ATE382327T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05014134A EP1738747B1 (de) 2005-06-30 2005-06-30 Verwendung von Salicyloyl-Sphingoidbase zur Behandlung oder Verhinderung von Cellilitis

Publications (1)

Publication Number Publication Date
ATE382327T1 true ATE382327T1 (de) 2008-01-15

Family

ID=35134236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05014134T ATE382327T1 (de) 2005-06-30 2005-06-30 Verwendung von salicyloyl-sphingoidbase zur behandlung oder verhinderung von cellilitis

Country Status (6)

Country Link
US (2) US20070003509A1 (de)
EP (1) EP1738747B1 (de)
AT (1) ATE382327T1 (de)
DE (1) DE602005004139T2 (de)
ES (1) ES2298885T3 (de)
PL (1) PL1738747T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080059313A1 (en) * 2006-08-30 2008-03-06 Oblong John E Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
PL2051691T3 (pl) * 2006-10-13 2010-10-29 Evonik Degussa Gmbh Kompozycja do leczenia skóry
WO2008110672A1 (fr) * 2007-03-12 2008-09-18 L'oreal Utilisation d'un derive c-glycoside a titre d'agent anti-oxydant
DE102007049612A1 (de) * 2007-10-17 2009-06-10 Evonik Goldschmidt Gmbh Bioaktive Zusammensetzung für kosmetische Anwendungen
AU2009219789A1 (en) * 2008-02-29 2009-09-03 The Procter & Gamble Company Hair care compositions and methods for increasing hair diameter
DE102008022392A1 (de) * 2008-05-06 2009-11-12 Evonik Goldschmidt Gmbh Kosmetika enthaltend Zistrosenkraut-Extrakte
DE102009044974A1 (de) * 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von Dihydroquercetin und mindestens einer Aminosäure zur positiven Beeinflussung des natürlichen Pigmentierungsprozesses
WO2011044207A2 (en) * 2009-10-06 2011-04-14 L'oreal S.A. Compositions containing a high concentration of polar sphingolipid(s)
JP5647786B2 (ja) * 2009-12-28 2015-01-07 花王株式会社 油性組成物
DE102012007491A1 (de) 2012-04-11 2013-10-17 Evonik Industries Ag Neue Enzyme
WO2014038097A1 (en) * 2012-09-07 2014-03-13 Shiseido Company, Ltd. Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
MX2015015676A (es) 2013-05-16 2016-03-04 Procter & Gamble Composiciones de espesamiento para el cabello y metodos de uso.
DE102013215434A1 (de) 2013-08-06 2015-02-12 Evonik Industries Ag Methionyl-Methionin-Stereoisomere und deren Verwendung in Kosmetika
CA2927282C (en) 2013-12-20 2023-06-27 Colgate-Palmolive Company Tooth whitening oral care product with core shell silica particles
MX369280B (es) 2013-12-20 2019-11-04 Colgate Palmolive Co Particulas de silice del tipo de nucleo y recubrimiento y usos de las mismas como agente antibacteriano.
BR112020011355B1 (pt) 2017-12-12 2022-09-06 Colgate-Palmolive Company Composição antitranspirante e/ou desodorante e método para aumentar a produção de fibrilina e procolágeno na pele
PY1917053A (es) * 2018-03-09 2019-09-13 Ocusoft Inc Composiciones tópicas para el cuidado de la piel
CN108543106A (zh) * 2018-06-19 2018-09-18 珠海市雅莎医疗器械有限公司 一种祛斑美白的皮肤护理敷料及其制备方法
CN109394561B (zh) * 2018-12-14 2021-11-02 完美（中国）有限公司 一种祛黄美白组合物及应用和制备方法
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물
KR102592150B1 (ko) 2020-07-09 2023-10-20 크로다코리아 주식회사 살리실산 유도체를 포함하는 신규한 스핑고지질 및 이를 포함하는 조성물
CN115260091B (zh) * 2022-08-05 2025-06-06 深圳市迪克曼生物科技有限公司 含环状羧酸的神经酰胺类化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9308103D0 (en) * 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
US5705170A (en) * 1995-10-24 1998-01-06 Plantech International, Inc. Herbal cellulite treatments
DE69802908T2 (de) * 1997-03-13 2004-05-06 Cosmoferm B.V. Salicylsäure - sphingoidbase derivate und ihre verwendung
ES2210767T3 (es) * 1997-05-02 2004-07-01 Cosmoferm B.V. Composiciones antimicrobianas para uso topico.
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
EP1287815A1 (de) * 2001-08-31 2003-03-05 Cosmoferm B.V. Verwendung einer Sphingoidbase zur Inhibierung von Ceramidase-Aktivität
US20050175559A1 (en) * 2004-02-10 2005-08-11 Pcr Technology Holdings, Lc Method and preparation for reducing skin hyperpigmentation

Also Published As

Publication number Publication date
EP1738747B1 (de) 2008-01-02
US20080249073A1 (en) 2008-10-09
PL1738747T3 (pl) 2008-09-30
ES2298885T3 (es) 2008-05-16
DE602005004139D1 (de) 2008-02-14
US20070003509A1 (en) 2007-01-04
DE602005004139T2 (de) 2009-01-02
EP1738747A1 (de) 2007-01-03

Similar Documents

Publication Publication Date Title
DE602005004139D1 (de) Verwendung von Salicyloyl-Sphingoidbase zur Behandlung oder Verhinderung von Cellilitis
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
ATE520391T1 (de) Verwendung von einem phaeodactylum-algen-extrakt zur förderung der hautzellen-proteasom-aktivität
ATE499105T1 (de) Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
DE60041394D1 (de) N-Acetylhydroxyprolin zur Verbesserung der Feuchtigkeitsspeicherungsfunktion der Epidermis
ATE376446T1 (de) Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung
WO2001094381A3 (fr) Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE493964T1 (de) Verfahren zur reduzierung des auftretens von kränklicher oder blasser haut
DE60101669T2 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
DE602004003587D1 (de) Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite
EP1435899A4 (de) Zusammensetzung zur förderung des haarwachstums
ATE542536T1 (de) 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen
BRPI0415229A (pt) composição para promoção de produção de colágeno
ATE427956T1 (de) Ckrox-peptide und ihre analoge zur behandlung von hautalterung
DE602005023468D1 (de) Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen
ATE493966T1 (de) Mittel zur förderung der hautkollagenproduktion
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
ATE337005T1 (de) Nagellack enthaltend tazaroten und verwendung dessen zur behandlung und/oder zur prävention von psoriasis
DE602006007163D1 (de) Kosmetische verfahren zur verwendung bei der hautglättung
DE602004001509D1 (de) Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung
DE602005016198D1 (de) Verwendung von Hülsenfrüchten zur Herstellung von Produkten zum Schutz oder Behandlung von radiotherapie-bedingten Hautschäden
ATE532883T1 (de) Voc-arme fettungsmittel, ihre verwendung in der herstellung und/oder behandlung von leder und häuten, sowie das ensprechende herstellungs- bzw. behandlungsverfahren
ATE347883T1 (de) Verwendung von n-(2-aryl-propionyl)-sulfonamiden zur behandlung von rückenmarkverletzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties